Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON VENUS REMEDIES BIOCON /
VENUS REMEDIES
 
P/E (TTM) x 19.7 15.1 130.5% View Chart
P/BV x 1.8 1.0 189.5% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 BIOCON    VENUS REMEDIES
EQUITY SHARE DATA
    BIOCON
Mar-23
VENUS REMEDIES
Mar-23
BIOCON /
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs388379 102.3%   
Low Rs192145 132.1%   
Sales per share (Unadj.) Rs93.1415.5 22.4%  
Earnings per share (Unadj.) Rs5.419.9 27.0%  
Cash flow per share (Unadj.) Rs14.644.0 33.2%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs146.5344.3 42.6%  
Shares outstanding (eoy) m1,200.6013.37 8,979.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.10.6 493.8%   
Avg P/E ratio x54.113.2 410.4%  
P/CF ratio (eoy) x19.85.9 333.0%  
Price / Book Value ratio x2.00.8 259.9%  
Dividend payout %28.00-   
Avg Mkt Cap Rs m347,8143,501 9,933.3%   
No. of employees `000NANA-   
Total wages/salary Rs m21,810570 3,823.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,7425,555 2,011.5%  
Other income Rs m7,681103 7,441.4%   
Total revenues Rs m119,4235,658 2,110.6%   
Gross profit Rs m16,611602 2,759.3%  
Depreciation Rs m11,131323 3,446.3%   
Interest Rs m4,1903 142,517.0%   
Profit before tax Rs m8,971379 2,365.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,541114 2,235.8%   
Profit after tax Rs m6,430266 2,420.4%  
Gross profit margin %14.910.8 137.2%  
Effective tax rate %28.330.0 94.5%   
Net profit margin %5.84.8 120.3%  
BALANCE SHEET DATA
Current assets Rs m123,3403,230 3,819.1%   
Current liabilities Rs m85,107826 10,307.3%   
Net working cap to sales %34.243.3 79.1%  
Current ratio x1.43.9 37.1%  
Inventory Days Days12937 349.4%  
Debtors Days Days117504 23.2%  
Net fixed assets Rs m394,0782,781 14,169.1%   
Share capital Rs m6,003134 4,490.9%   
"Free" reserves Rs m169,9264,470 3,801.7%   
Net worth Rs m175,9294,603 3,821.8%   
Long term debt Rs m152,905387 39,531.8%   
Total assets Rs m517,4186,011 8,608.1%  
Interest coverage x3.1130.0 2.4%   
Debt to equity ratio x0.90.1 1,034.4%  
Sales to assets ratio x0.20.9 23.4%   
Return on assets %2.14.5 45.9%  
Return on equity %3.75.8 63.3%  
Return on capital %4.07.7 52.2%  
Exports to sales %3.10-   
Imports to sales %6.00-   
Exports (fob) Rs m3,467NA-   
Imports (cif) Rs m6,654NA-   
Fx inflow Rs m3,4670-   
Fx outflow Rs m6,6540-   
Net fx Rs m-3,1870-   
CASH FLOW
From Operations Rs m18,525366 5,057.7%  
From Investments Rs m-142,818-508 28,097.2%  
From Financial Activity Rs m130,487-6 -2,297,306.3%  
Net Cashflow Rs m6,411-220 -2,908.3%  

Share Holding

Indian Promoters % 40.4 41.8 96.6%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 1.6 1,324.5%  
FIIs % 6.6 1.6 411.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 58.2 67.6%  
Shareholders   434,339 19,560 2,220.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs VENUS REMEDIES Share Price Performance

Period Biocon VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 3.04% 7.56% 1.18%
1-Month -2.42% -3.64% -0.75%
1-Year 30.66% 104.08% 61.82%
3-Year CAGR -13.51% 4.79% 18.16%
5-Year CAGR -2.70% 58.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Biocon, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.